SMTL ID : 4yz9.2 (2 other biounits)

Crystal Structure of human phosphorylated IRE1alpha in complex with a type III kinase inhibitor (GSK2850163A)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.46 Å

Oligo State

monomer

Ligands

1 x 4K7: (5R)-2-(3,4-dichlorobenzyl)-N-(4-methylbenzyl)-2,7-diazaspiro[4.5]decane-7-carboxamide(Non-covalent)

4K7.1: 25 residues within 4Å: Chain A: G.19, A.20, E.21, T.23, K.38, I.40, C.44, F.47, A.48, E.51, V.52, L.55, V.64, I.65, R.66, Y.67, I.79, I.81, L.118, I.123, V.124, H.125, R.126, S.149, D.150 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:A.20, A:V.52, A:I.65, A:Y.67, A:I.79, A:I.81, A:D.150 Hydrogen bonds: A:K.38, A:E.51, A:R.126 Salt bridges: A:E.51, A:D.150 pi-Stacking: A:H.125 pi-Cation interactions: A:K.38

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Concha, N.O. et al., Long-Range Inhibitor-Induced Conformational Regulation of Human IRE1 alpha Endoribonuclease Activity. Mol.Pharmacol. (2015)

Release Date

2015-11-11

Peptides

Serine/threonine-protein kinase/endoribonuclease IRE1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Serine/threonine-protein kinase/endoribonuclease IRE1

Related Entries With Identical Sequence